Detalhe da pesquisa
1.
Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition.
J Natl Compr Canc Netw
; 21(3): 232-234, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758579
2.
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab.
Future Oncol
; 19(33): 2213-2225, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589131
3.
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(6): 786-795, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386568
4.
A case study on severe psychiatric symptoms induced by lorlatinib.
Psychooncology
; 33(1): e6283, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38282214
5.
Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
Gynecol Oncol
; 139(2): 236-41, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26404183
6.
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
J Thorac Oncol
; 19(3): 500-506, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012986
7.
Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung.
Mod Pathol
; 26(2): 239-46, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22996376
8.
Neoadjuvant immunotherapy in resectable non-small-cell lung cancer.
Ther Adv Med Oncol
; 15: 17588359231163798, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37007633
9.
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy.
Cancer Immunol Res
; 11(2): 164-170, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512052
10.
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.
J Thorac Cardiovasc Surg
; 166(3): 637-654, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306641
11.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Lung Cancer
; 178: 166-171, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868177
12.
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report.
J Thorac Oncol
; 18(5): 650-656, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641093
13.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Cancer Discov
; 13(7): 1556-1571, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068173
14.
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
Cancer Discov
; 13(6): 1386-1407, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061969
15.
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
J Thorac Oncol
; 18(10): 1290-1302, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702631
16.
Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice.
JTO Clin Res Rep
; 3(5): 100310, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35498382
17.
Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer.
Cancer Discov
; 12(4): 1002-1021, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078784
18.
Into the Clinic With Nivolumab and Pembrolizumab.
Oncologist
; 21(5): 527-8, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026678
19.
Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report.
JTO Clin Res Rep
; 2(2): 100130, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589989
20.
ALK Gene Rearrangements in Lung Adenocarcinomas: Concordance of Immunohistochemistry, Fluorescence In Situ Hybridization, RNA In Situ Hybridization, and RNA Next-Generation Sequencing Testing.
JTO Clin Res Rep
; 2(10): 100223, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34746883